Lorlatinib

Information about Lorlatinib

Lorlatinib uses

Lorlatinib is used in the treatment of non-small cell lung cancer.

How lorlatinib works

Lorlatinib is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Common side effects of lorlatinib

Anemia (low number of red blood cells), Fatigue, Diarrhea, Vomiting, Edema (swelling), Fever, High blood pressure, Cough, Joint pain, Peripheral neuropathy (tingling and numbness of feet and hand), Weight gain, Breathlessness, Mood changes, Hypercholesterolemia (high cholesterol), Increased triglyceride level in blood, Increased glucose level in blood, Sleep disorder, Hallucination, Pneumonia, Altered mental state, Low albumin level in blood, Confusion, Cognitive disorder, Vision disorder, Atrioventricular block, Interstitial lung disease

Available Medicine for Lorlatinib

  • ₹1 to ₹312000
    Pfizer Ltd
    4 variant(s)

Content on this page was last updated on 22 December, 2022, by Dr. Varun Gupta (MD Pharmacology)